SCHEMBL8439181

SCHEMBL8439181

CCCCc1ncc(CCl)n1Cc1ccc(C(=O)OC)cc1

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 13/20 0.60
AGTR2 P50052 3/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8522168 0.92 AGTR1 (0.59) AGTR1AGTR2
SCHEMBL7890351 0.91 AGTR1 (0.60) AGTR1AGTR2
SCHEMBL8435232 0.90 AGTR1 (0.59) AGTR1AGTR2
SCHEMBL9204574 0.89 AGTR1 (0.58) AGTR1AGTR2
SCHEMBL8434213 0.87 AGTR1 (0.56) AGTR1AGTR2
SCHEMBL8433706 0.86 AGTR1 (0.55) AGTR1AGTR2
SCHEMBL8438466 0.85 AGTR1 (0.59) AGTR1AGTR2
SCHEMBL1256316 0.84 AGTR1 (0.58) AGTR1AGTR2
SCHEMBL8586238 0.84 AGTR1 (0.54) AGTR1AGTR2
SCHEMBL946900 0.83 AGTR1 (0.67) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0427463-B1 Substituted N-(imidazolyl)alkyl alanine derivatives SMITHKLINE BEECHAM CORP (US) 1995-03-08 EP claimed
EP-0427463-A1 Substituted N-(imidazolyl)alkyl alanine derivatives SMITHKLINE BEECHAM CORPORATION (US) 1991-05-15 EP claimed
US-5929249-A ANGIOTENSIN II RECEPTOR ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1999-07-27 US disclosed
US-5728842-A ANGIOTENSIN II RECEPTOR ANTAGONIST SMITHKLINE BEECHAM CORPORATION (US) 1998-03-17 US disclosed
WO-1994000120-A1 CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1994-01-06 WO disclosed
WO-1993006828-A1 MEDICAMENT FOR THE TREATMENT OF ANXIETY SMITHKLINE BEECHAM CORPORATION (US) 1993-04-15 WO disclosed